- 29.7k views
India’s First Single-hole Robotic Cholecystectomy
A complex procedure was successfully performed to treat severe lumbar canal stenosis in a 40-year-old male patient weighing 185kg. Given the urgency of the situation and the patient's extreme weight, an intricate spinal decompression and stabilisation surgery was performed. Thereafter the patient regained his ability to walk and control his body functions. India's first-ever single-hole robotic cholecystectomy using conventional robotic instruments was successfully performed for a 60-year old male patient diagnosed with cholelithiasis, thickened gallbladder containing multiple large calculi each over 3 cm in size. This procedure, typically available in western countries with expensive specialized equipment, marks a significant milestone in Indian healthcare. The surgery was successfully completed within one hour without any major complications.
About the Speaker
Dr. Arun Prasad
Surgical Gastroenterologist, Bariatrics Surgeon, Indraprastha Apollo Hospitals, New Delhi
Dr. Arun Prasad is currently working as Surgical Gastroenterologist & Bariatric Surgeon at Indraprastha Apollo Hospitals, New Delhi. With 35 years of surgical experience, this surgeon is among the most seasoned in India and globally, pioneering various advanced techniques, including laparoscopy since 1990, advanced laparoscopy in 1997, single incision laparoscopy in 2010, bariatric surgery in 2004, robotic surgery in 2012, and bariatric endoscopy in 2018. A graduate of the Armed Forces Medical College, Pune, he completed his master's in surgery at Maulana Azad Medical College, New Delhi, in 1988, and received higher surgical training in GI surgery in the UK, where his team initiated laparoscopic surgery. After earning his FRCS in 1990 and working at Charing Cross Medical School, London, he returned to India in 1996, joining Apollo Hospitals as one of the youngest senior consultants. Recognized as a pioneer in laparoscopy in both the UK and India, he was awarded the prestigious FACS (USA) in 2019. His achievements include performing over 6000 laparoscopic cholecystectomies, 2000 laparoscopic hernia surgeries, and pioneering bariatric surgery in India with over 1000 procedures. He also led the way in bariatric endoscopy, robotic bariatric surgery, and GI surgery, holding several records in these fields.
Upcoming Case Discussions
Treatment of Renal Disease in ANCA Vasculitis
The treatment of renal disease in ANCA-associated vasculitis (AAV) typically involves a combination of immunosuppressive therapies to control inflammation and prevent further kidney damage. First-line treatment often includes high-dose corticosteroids and cyclophosphamide or rituximab, both of which help to induce remission by targeting the underlying immune system dysfunction. In cases of kidney failure or rapidly progressive glomerulonephritis, plasmapheresis may be used to remove circulating autoantibodies. Once remission is achieved, maintenance therapy with lower doses of immunosuppressants, such as azathioprine or mycophenolate mofetil, is used to prevent relapses and preserve kidney function.
NIV in Acute Respiratory Failure
Dr Viny Kantroo is a Chest, Critical Care & Sleep medicine specialist based in Delhi, boasting over more than 15 years of professional experience. She is currently practising as a full time Senior consultant in Indraprastha Apollo Hospitals New Delhi and Visiting Consultant Apollo Hospitals Noida in the department of Respiratory, Critical Care and Sleep Medicine. She is recognised for her expertise in various aspects of Chest medicine, which includes EBUS (Convex probe, Radial), Bronchoscopic procedures, pleural effusion management, interstitial lung disease, Covid-19, lung cancer, pneumonia, and intensive care patient management. Dr Kantroo is renowned not only for her medical proficiency but also for her empathy and positive attitude towards patient care. Patients consulting with Dr Viny can be assured of receiving an accurate diagnosis and effective treatment, thanks to her commitment to prompt and comprehensive care.
Pulmonary Tuberculosis: Challenges in Diagnosis
Diagnosing pulmonary tuberculosis (TB) poses significant challenges, particularly in resource-limited settings. The disease often mimics other respiratory conditions, leading to delayed or missed diagnoses. Traditional diagnostic methods like sputum smear microscopy have limited sensitivity, especially in HIV co-infected or low-bacterial-load patients. Advanced techniques such as GeneXpert and culture tests, though more accurate, are often unavailable in remote areas. Children and immunocompromised patients present additional hurdles due to atypical symptoms and difficulty obtaining diagnostic samples. Non-specific imaging findings further complicate diagnosis. Addressing these challenges requires expanded access to molecular diagnostics, improved point-of-care tools, and greater healthcare awareness.
AI in Genetics and Genomics
AI is revolutionizing genetics and genomics by enabling faster and more accurate analysis of complex genetic data. Machine learning algorithms can identify patterns in DNA sequences, helping to discover new genetic variants linked to diseases. Additionally, AI assists in predicting gene functions, personalizing medicine, and accelerating drug development. Its integration promises significant advancements in understanding genetic diseases and improving healthcare outcomes.
Management of Pediatric Type 1 Diabetes
Pediatric type 1 diabetes management focuses on maintaining glycemic control while supporting normal growth. Insulin therapy, via multiple daily injections or pumps, is essential, with doses adjusted based on blood glucose monitoring or continuous glucose monitoring (CGM). Nutrition plans emphasizing carbohydrate counting and balanced meals are crucial, alongside adjustments for physical activity to prevent glucose fluctuations. Education for families on recognizing hypo- and hyperglycemia symptoms and managing sick days is vital. Regular follow-ups with a pediatric endocrinologist help monitor HbA1c levels, growth, and complications. Psychosocial support is key for ensuring adherence and addressing emotional challenges.